CELLECTIS

French limited liability company (société anonyme)

with share capital of € 4.997.776,75

Registered Office: 8, rue de la Croix Jarry - 75013 Paris Paris trade and companies register No. 428 859 052 (the "Company")

Information regarding the director nominee

SHAREHOLDERS MEETING OF JUNE 28, 2024

  1. NAME AND FIRST NAME: SOURDIVE, David
  2. DATE AND PLACE OF BIRTH: December 26, 1966 (France)
  3. AGE : 57
  4. NATIONALITY : French
  5. PROFESSIONAL PROFILE AND PROFESSIONAL ACTIVITIES DURING THE PAST FIVE YEARS

On-going:

  • MEDLIS, director,
  • Exeliom SAS, director,
  • Cell-EasySAS, director,
  • hema.to GmbH, director,
  • Aqemia SAS, director

Past :

  • Eukarÿs, SAS, director,
  • Omics SAS, director,
  • Enobraq, director,
  • Mablink SAS, director

6. CURRENT POSITION IN THE COMPANY

Executive Vice President, CMC & Manufacturing

Director, deputy chief executive officer,

7. COMPANY SHARES OWNED BY THE DIRECTOR NOMINEE

987 655 Shares

1 137 325 Stock Options

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Cellectis SA published this content on 11 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 June 2024 14:07:03 UTC.